Olivia Goldhill

Existing therapies don't work well for many people with PTSD, and no new drug for the disorder has been approved in more than two decades.

Shifting from topic to topic, with few connections, is one of several disjointed and occasionally incoherent verbal habits that seem to have increased in Trump’s speech.

The FDA said it’s investigating Lykos studies of MDMA treatment for PTSD. Key people involved in misconduct claims have yet to be contacted.

Despite an advisory panel’s strong criticisms of MDMA, the FDA’s favorable view of psychedelics suggests an approval is quite possible.

The psychedelics company oversaw a pattern of lapses during its clinical trials, according to former employees who spoke with STAT.

FDA advisers weigh the first use of psychedelic therapy for post-traumatic stress disorder, review safety and efficacy data from MDMA trials.

As Lykos Therapeutics seeks a landmark approval of psychedelic therapy for PTSD, it will face scrutiny from an FDA advisory panel next week.

FDA urged to probe claims of underreported adverse events in Lykos Therapeutics trials of psychedelic therapy for PTSD.

STAT surveyed 100 hospitals across 50 states about changes in maternal care after overturning of Roe v. Wade. Only six agreed to speak.

Advocates say there isn’t capacity elsewhere to see all the patients who will be denied abortion access by Florida’s six-week ban.